Join the Oncology Voice Network. Join for Free
Difficult KOLs: How to overcome challenges, find success and gain access
Medical Science Liaisons Key Opinion Leaders pre-call planning KOL relationship building overcoming challenges

Difficult KOLs: How to overcome challenges, find success and gain access


Share This Article


Summary

In this episode, Andrea Johnson joins Tom Caravela to delve into effective strategies for Medical Science Liaisons. They explore the value of Key Opinion Leaders (KOLs), emphasizing the importance of pre-call planning and preparation. Andrea shares techniques for building strong connections with KOLs and utilizing internal resources effectively. The conversation covers networking tips, the significance of text relationships, and handling challenging interactions. They discuss overcoming negative experiences and the importance of respect in professional relationships. The episode concludes with key takeaways and a call to action for listeners.

My guest today, is Andrea Johnson, National Director, MSLs. Andrea discusses how to overcome challenges, find success and gain access to difficult KOLs

Andrea shares…

👉 Interesting stories about difficult KOLs
👉 Some effective strategies and best practices for turning around difficult KOLs
👉 Practical tips for KOL relationship building
👉 How important pre-call planning is as a practice
👉 What ideas or creative strategies she has seen work for gaining access with tough KOLs

Click for Source
Medical Science Liaisons, Key Opinion Leaders, pre-call planning, KOL relationship building, overcoming challenges

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Social Media Listening Evolved
Partner Avatar MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson

Social Media Listening Evolved

Podcast
How to Start Presenting Like a Pro
Partner Avatar MSL Talk: Tom Caravela

How to Start Presenting Like a Pro

Article
The Oncology Data Network (ODN): Methodology, Challenges, and Achievements
OVN Avatar Ashley Woolmore , Dirk Arnold , Jean‐Yves Blay , Christian Buske , Alfredo Carrato , Winald Gerritsen , Marc Peeters , Jesus Garcia‐Foncillas , David Kerr

The Oncology Data Network (ODN): Methodology, Challenges, and Achievements

Article
Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs
OVN Avatar Alyson Haslam, PhD; Vinay Prasad, MD, MPH

Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs

Article
Loose Regulatory Standards Portend a New Era of Imprecision Oncology
OVN Avatar Ali Raza Khaki

Loose Regulatory Standards Portend a New Era of Imprecision Oncology

Article
Expert perspectives live from ASCO® 2025
Partner Avatar iNIZIO

Expert perspectives live from ASCO® 2025

Explore OVN